ClinicalTrials.gg
RecruitingNCT05337982Updated Dec 23, 2025

Eccentric Muscle Training, Stimulation, and Biomarkers in SCI

An interventional study of Downhill Eccentric Treadmill Training with Electrical Stimulation in Spinal Cord Injuries and Healthy, sponsored by Ohio State University. Recruiting at 2 sites in 2 countries. Open to participants aged 18 Years to 85 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by Ohio State University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2022; still recruiting 4 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
49
Allocation
Randomized
Ages
18 Years to 85 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 13 studies in Spinal Cord Injuries by Ohio State University — 3 open to participants now, 4 under way, none of them phase 3. Spinal Cord Injuries · Ohio State University.

Planned enrollment
Largest of 10
49 · median 21
Started
2022
the only one that year
No phase
9 of 13
3 open now
Registered
8th of 13
by date

Among the 13 studies in Spinal Cord Injuries by Ohio State University, this one has the largest planned enrollment of the 10 interventional ones that give a count, is the only one that started in 2022, is one of 9 with no phase, and was the 8th registered.

Spinal Cord Injuries

2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.

Browse Spinal Cord Injuries studies →

Open to participants now

3 of the 13 studies in Spinal Cord Injuries by Ohio State University are open now, in 2 countries. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.

This study: 18 Years to 85 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 13 studies in Spinal Cord Injuries by Ohio State University, or all of them as a file.
02

Study summary

The investigators are studying a new rehabilitation treatment for individuals trying to recover walking after spinal cord injury (SCI). The investigators will test conditions in the blood and spinal fluid to determine the best time to start this new training program. This will include checking for certain features called biomarkers by testing participants' spinal fluid and blood and compare these features to individuals without SCI. These features will help investigators determine when to start the new training program, either right away or waiting for 3 months. The new training program uses walking downhill on a slight slope on a treadmill while muscles that are not working normally are stimulated to contract using low levels of electricity. Adding this stimulation will allow people to practice walking and other skills even though full muscle control has not recovered. This new program will be in addition to any other rehabilitation therapy and will not replace standard rehabilitation. The hope is to see if downhill training with muscle stimulation, when delivered at the most ideal time, will improve trunk and leg movement, walking, and overall function. This recovery of movement and function will be compared to people with SCI receiving standard rehabilitation alone. Certain regions of the brain and spinal cord will also be studied using MRI scans to determine if these are affected by the training and compare to individuals without SCI. The total length of the study for SCI participants will be up to 16 weeks if in the standard of care group and up to 33 weeks if in the trained group. Healthy control participants will be involved for 1-2 visits.

Read the detailed description

SCI group: Individuals 3 months (+/-2 months) after SCI will be randomized into standard of care control group or augmented rehabilitation group (DownHill training with STIMulation = dhSTIM group). The study statistician will produce the randomization schedule with varying permuted blocks of size 3 and 6. The randomization schedule will be uploaded to REDCap for randomization of subjects at the time of enrollment into the study. The dhSTIM group will have cerebrospinal fluid (CSF) and blood collected and analyzed. These will be collected for research purposes only by the study's experienced proceduralist unless it is being collected clinically within the required timeframe for the study. CSF is collected via lumbar puncture under guided fluoroscopy which is a standardized technique to collect CSF and minimizes risks. If not enough CSF is collected on the first attempt, a second attempt may be required which is not expected due to the use of guided fluoroscopy but may occur in standard practice. Based on inflammatory status relative to healthy controls, the dhSTIM group will be directed to a Go group - immediate start at \~3 months) or No Go Group - delayed start at \~6 months. All SCI groups (dhSTIM Go, dhSTIM No Go, SOC) will also continue with regular outpatient therapy. The augmented rehabilitation groups and healthy controls will undergo MRI. The dhSTIM training will be a 12-week downhill training program combined with Xcite electrical stimulation 3 times a week. Participants will walk downhill on a treadmill with a harness for body weight support and trainers assisting as needed. All SCI groups (dhSTIM Go, dhSTIM No Go, SOC) will participate in pre, post, and 4 week follow-up assessments as follows: Biomechanical analysis will include kinematics, kinetics, and electromyography (EMG) while on the treadmill. Clinical outcome measures will include: American Spinal Injury Association (ASIA) Impairment scale (AIS), International standards for neurological classification of spinal cord injury (ISNCSCI), Autonomic Standards Assessment Form, Neuromuscular Recovery Scale, Neuropathic Pain Symptom Inventory, Pain Numeric Rating Scale, Spinal Cord Injury Independence Measure (SCIM3), 6 minute walk test (MWT), 10 meter walk test (MWT). Clinical outcome measures conducted as standard measures will be collected will be accessed via medical record when available. If absent from the medical record, they will be collected by a rater blind to group assignment. Leg strength will also be measured using the Biodex system. An additional MRI scan will be obtained at the end of the 12 week training period for the dhSTIM GO and dhSTIM No Go groups. Healthy Control Group: Healthy participants from the community will volunteer for the CSF and blood collection by the study's experienced proceduralist. CSF will be collected from at least half of the healthy controls prior to enrolling participants with SCI to provide a sample of normal levels of inflammatory genes and concentration of microglia-like cells as a baseline. CSF is collected for research purposes only via lumbar puncture under guided fluoroscopy which is a standardized technique to collect CSF and minimizes risks. If not enough CSF is collected on the first attempt, a second attempt may be required which is not expected due to the use of guided fluoroscopy but may occur in standard practice. When possible, they will also participate in one MRI scan of the brain and spinal cord. Due to MRI restrictions, some healthy controls may only be able to participate in biomarkers collection, some to only participate in MRI scans and some to participate in both types of collection. Individuals for the healthy control group will be enrolled until a total of n=10 +1 for biomarkers and n=10+1 for MRI is reached. One additional individual is allocated to account for dropouts. If there no individuals are able to take part in both MRI and fluid biomarker collection, then up to n=22 healthy controls will be enrolled.

03

Conditions studied

  • Spinal Cord Injuries
  • Healthy

Keywords

  • Spinal Cord Injury
  • SCI
  • Biomarkers
  • MRI
  • Locomotor Training
  • Downhill
  • Neuromodulation
  • Electrical Stimulation
  • CSF
  • Rehabilitation
  • Physical Therapy
  • Eccentric
  • Treadmill
  • blood draw
04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

SCI participants WITHIN 1-5 MONTHS OF THEIR INJURY:

  • Discharged from inpatient rehabilitation;
  • AIS A-D at neurologic level C1-T10;
  • 18-85 years old.

Healthy controls:

  • Adults 18-85 years old;
  • no recent major musculoskeletal injury;
  • no recent surgery.

Exclusion criteria

EXCLUSION CRITERIA:

SCI participants:

  • Use of botox in the past 3 months that reduces skeletal muscle function;
  • other neurologic conditions (i.e. brain injury, stroke, );
  • current cancer diagnosis;
  • active deep vein thrombosis and anti-coagulation therapy;
  • skin wounds in regions that interfere with harness, stimulation pads or hand placement needed for training.
  • pregnancy;
  • ventilator-dependence;
  • cognitive conditions that preclude providing .
  • Implanted medical devices that are for electrical stimulation or MRI *(If SCI participants have conditions contraindicated for MRI they may still participate in the remainder of study activities without myelin status as an outcome measure. SCI is a rare condition therefore this is necessary in order to achieve the required sample size.)

Healthy controls:

  • Implanted medical devices that are contraindicated for MRI (MRI participants only);
  • neurologic conditions (i.e. brain injury, stroke, HIV);
  • current cancer diagnosis;
  • clotting disorders requiring anti-coagulation therapy;
  • inflammatory conditions like arthritis, ulcerative colitis, lupus, etc;
  • pregnancy;
  • fear of needles;
  • claustrophobia;
  • cognitive conditions that preclude providing informed consent.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
49 participants (estimated)

Study arms

  • Experimental
    SCI Go

    Participants with SCI randomized to the experimental group that have biomarkers that indicate low levels of inflammation will start immediately.

    Other: Downhill Eccentric Treadmill Training with Electrical Stimulation

  • Experimental
    SCI No Go

    Participants with SCI randomized to the experimental group that have biomarkers that indicate high levels of inflammation will have a delayed start of 3 months.

    Other: Downhill Eccentric Treadmill Training with Electrical Stimulation

  • No intervention
    SCI SOC

    Participants with SCI randomized to the standard of care (SOC) group will continue with regular therapy.

  • No intervention
    Healthy Control

    Healthy controls will provide biomarker and/or myelin (MRI) data

Interventions

  • OtherDownhill Eccentric Treadmill Training with Electrical Stimulation

    Participants will walk on a treadmill with a downward incline with support from a harness and assistance from trainers as needed. Participants will also simultaneously receive stimulation to their muscles including their trunk and legs. Each session will include 20 minutes of walking divided into 5 minute bouts with 5 minute rest breaks in between for 3 sessions per week for 12 weeks.

06

What researchers measure

Primary outcomes

  1. Change from baseline in electromyography of eccentric acting muscles

    Muscle activation during weight acceptance while walking on a treadmill

    Time frame: 12 weeks

  2. Change from baseline in kinetics during weight acceptance

    Peak magnitude of loading response as measured by the peak magnitude of power absorption during the weight acceptance phase of walking on a treadmill

    Time frame: 12 weeks

  3. Change from baseline in kinematics during weight acceptance: hip range of motion

    Range of motion of the hip joint during walking on a treadmill

    Time frame: 12 weeks

  4. Change from baseline in kinematics during weight acceptance: knee range of motion

    Range of motion of the knee joint during walking on a treadmill

    Time frame: 12 weeks

  5. Change from baseline in kinematics during weight acceptance: ankle range of motion

    Range of motion of the ankle joint during walking on a treadmill

    Time frame: 12 weeks

  6. Change from baseline in kinematics during weight acceptance: hip acceleration

    Acceleration of the hip joint during walking on a treadmill

    Time frame: 12 weeks

  7. Change from baseline in kinematics during weight acceptance: knee acceleration

    Acceleration of the knee joint during walking on a treadmill

    Time frame: 12 weeks

  8. Change from baseline in kinematics during weight acceptance: ankle acceleration

    Acceleration of the ankle joint during walking on a treadmill

    Time frame: 12 weeks

  9. Change from baseline in myelination in brain and spinal cord measured by Magnetic Resonance Imaging (MRI)

    Myelin spared pre and post intervention in the motor areas of the brain and cervical spinal cord compared to healthy controls

    Time frame: 12 weeks

Secondary outcomes

  1. Change from baseline in ASIA Impairment Scale (AIS)

    Classification of injury using grades A, B, C, D or E indicating level of impairment including complete (A), sensory incomplete (B), or motor incomplete (C and D). A classification differences between C and D indicates if less or more than half (respectively) of myotomes below the level of injury are able to at least move through the full range of motion against gravity. A grade of E indicates normal sensory and strength function.

    Time frame: 12 weeks

  2. Change from 12 weeks to 16 weeks in American Spinal Injury Association (ASIA) Impairment Scale (AIS)

    Classification of injury using grades A, B, C, D or E indicating level of impairment including complete (A), sensory incomplete (B), or motor incomplete (C and D). A classification differences between C and D indicates if less or more than half (respectively) of myotomes below the level of injury are able to at least move through the full range of motion against gravity. A grade of E indicates normal sensory and strength function.

    Time frame: 16 weeks

  3. Change from baseline in International Standards for Neurological Classification of SCI (ISNCSCI): motor scores

    A universal classification tool for SCI based on a standardized sensory and motor assessment. The impairment scale involves both a motor and sensory examination to determine the sensory and motor levels for the right and left side, the overall neurological level of the injury and completeness of the injury i.e. whether the injury is complete or incomplete. Motor scores range from 0-50 for each the right and left sides and 50 for each the upper extremities and lower extremities. A higher score indicates better outcomes (strength).

    Time frame: 12 weeks

  4. Change from 12 weeks to 16 weeks in International Standards for Neurological Classification of SCI (ISNCSCI): motor scores

    A universal classification tool for SCI based on a standardized sensory and motor assessment. The impairment scale involves both a motor and sensory examination to determine the sensory and motor levels for the right and left side, the overall neurological level of the injury and completeness of the injury i.e. whether the injury is complete or incomplete. Motor scores range from 0-50 for each the right and left sides and 50 for each the upper extremities and lower extremities. A higher score indicates better outcomes (strength).

    Time frame: 16 weeks

  5. Change from baseline in International Standards for Neurological Classification of SCI (ISNCSCI): sensory scores

    A universal classification tool for SCI based on a standardized sensory and motor assessment. The impairment scale involves both a motor and sensory examination to determine the sensory and motor levels for the right and left side, the overall neurological level of the injury and completeness of the injury i.e. whether the injury is complete or incomplete. Sensory scores range from 0-112 for each the right and left sides. A higher score indicates better outcomes (sensation).

    Time frame: 12 weeks

  6. Change from 12 weeks to 16 weeks in International Standards for Neurological Classification of SCI (ISNCSCI): sensory scores

    A universal classification tool for SCI based on a standardized sensory and motor assessment. The impairment scale involves both a motor and sensory examination to determine the sensory and motor levels for the right and left side, the overall neurological level of the injury and completeness of the injury i.e. whether the injury is complete or incomplete. Sensory scores range from 0-112 for each the right and left sides. A higher score indicates better outcomes (sensation).

    Time frame: 16 weeks

  7. Change from baseline in International Standards for Neurological Classification of SCI (ISNCSCI): neurological level of injury (NLI)

    A universal classification tool for SCI based on a standardized sensory and motor assessment. The impairment scale involves both a motor and sensory examination to determine the sensory and motor levels for the right and left side, the overall neurological level of the injury and completeness of the injury i.e. whether the injury is complete or incomplete. NLI can range from the first level of the cervical spinal cord (C1) indicating tetraplegia (C1-thoracic, T1) to the final sacral level (S4-5) which would indicate paraplegia.

    Time frame: 12 weeks

  8. Change from 12 weeks to 16 weeks in International Standards for Neurological Classification of SCI (ISNCSCI): neurological level of injury (NLI)

    A universal classification tool for SCI based on a standardized sensory and motor assessment. The impairment scale involves both a motor and sensory examination to determine the sensory and motor levels for the right and left side, the overall neurological level of the injury and completeness of the injury i.e. whether the injury is complete or incomplete. NLI can range from the first level of the cervical spinal cord (C1) indicating tetraplegia (C1-thoracic, T1) to the final sacral level (S4-5) which would indicate paraplegia.

    Time frame: 16 weeks

  9. Change from baseline on Autonomic Standards Assessment Form

    International Standards to document remaining Autonomic Function after Spinal Cord Injury (ISAFSCI). Patient self-reported responses include normal (2) when there is no change in neurological control with respect to a specific function; reduced or altered (1) neurological control with regard to a specific function; absent (0) neurological control with regard to a specific function; and unable to assess a specific function (not testable, NT).

    Time frame: 12 weeks

  10. Change from 12 weeks to 16 weeks on Autonomic Standards Assessment Form

    International Standards to document remaining Autonomic Function after Spinal Cord Injury (ISAFSCI). Patient self-reported responses include normal (2) when there is no change in neurological control with respect to a specific function; reduced or altered (1) neurological control with regard to a specific function; absent (0) neurological control with regard to a specific function; and unable to assess a specific function (not testable, NT).

    Time frame: 16 weeks

  11. Change from baseline on Neuromuscular Recovery Scale (NRS) score

    Measures quality of movement without compensation. Scored in phases 1-4 with subphases A-C, with scores indicating most impairment (1A, numeric value of 1-1.99) to least impairment (4C, numeric value of 12).

    Time frame: 12 weeks

  12. Change from 12 weeks to 16 weeks on Neuromuscular Recovery Scale (NRS) score

    Measures quality of movement without compensation. Scored in phases 1-4 with subphases A-C, with scores indicating most impairment (1A, numeric value of 1) to least impairment (4C, numeric value of 12).

    Time frame: 16 weeks

  13. Change from baseline in 6 Minute Walk Test (6MWT)

    The distance walked overground within 6 minutes (meters).

    Time frame: 12 weeks

  14. Change from 12 weeks to 16 weeks in 6 Minute Walk Test (6MWT)

    The distance walked overground within 6 minutes (meters).

    Time frame: 16 weeks

  15. Change from baseline in 10 Meter Walk Test

    Gait speed - the time it takes to walk 10 meters (seconds)

    Time frame: 12 weeks

  16. Change from 12 weeks to 16 weeks in 10 Meter Walk Test

    Gait speed - the time it takes to walk 10 meters (seconds)

    Time frame: 16 weeks

  17. Change from baseline in Spinal Cord Independence Measure III (SCIM3) score

    Assessment of various activities of daily living. Scoring ranges per category: Self-care subscale, Items 1-4 (0-20); Respiration and sphincter management subscale, Items 5-8 (0-40); Mobility subscale, Items 9-17 (0-40) with higher scores indicating more independence.

    Time frame: 12 weeks

  18. Change from 12 weeks to 16 weeks in Spinal Cord Independence Measure III (SCIM3) score

    Assessment of various activities of daily living. Scoring ranges per category: Self-care subscale, Items 1-4 (0-20); Respiration and sphincter management subscale, Items 5-8 (0-40); Mobility subscale, Items 9-17 (0-40) with higher scores indicating more independence.

    Time frame: 16 weeks

  19. Change from baseline in Neuropathic Pain Symptom Inventory (NPSI) scale

    Characterization of neuropathic pain symptom severity in 5 subscales (burning, pressing, paroxysmal, evoked, and paresthesia/dysesthesia. Each item is scored on a scale of 0 (indicating no pain) to 10 (worst pain imaginable). Each subscale is added then divided by 100, giving a total score ranging from 0-1 with scores closest to 1 indicating worse pain.

    Time frame: 12 weeks

  20. Change from 12 weeks to 16 weeks in Neuropathic Pain Symptom Inventory (NPSI) scale

    Characterization of neuropathic pain symptom severity in 5 subscales (burning, pressing, paroxysmal, evoked, and paresthesia/dysesthesia. Each item is scored on a scale of 0 (indicating no pain) to 10 (worst pain imaginable). Each subscale is added then divided by 100, giving a total score ranging from 0-1 with scores closest to 1 indicating worse pain.

    Time frame: 16 weeks

  21. Change from baseline in Numeric Pain Rating Scale (NPRS)

    Subjective measure of the intensity of pain on a scale if 0-10, with a higher score indicating worse pain.

    Time frame: 12 weeks

  22. Change from 12 weeks to 16 weeks in Numeric Pain Rating Scale (NPRS)

    Subjective measure of the intensity of pain on a scale if 0-10, with a higher score indicating worse pain.

    Time frame: 16 weeks

  23. Change from baseline in Strength Testing

    Maximum voluntary eccentric knee flexion contraction after performing eccentric activity on the contralateral limb (i.e., the contralateral priming effect) measured by a Biodex.

    Time frame: 12 weeks

  24. Change from 12 weeks to 16 weeks in Strength Testing

    Maximum voluntary eccentric knee flexion contraction after performing eccentric activity on the contralateral limb (i.e., the contralateral priming effect) measured by a Biodex.

    Time frame: 16 weeks

  25. Change from baseline in electromyography of eccentric acting muscles at 12 weeks

    Muscle activation during weight acceptance while walking on a treadmill

    Time frame: 12 weeks

  26. Change from 12 weeks to 16 weeks in kinetics during weight acceptance

    Peak magnitude of loading response as measured by the peak magnitude of power absorption during the weight acceptance phase of walking on a treadmill

    Time frame: 16 weeks

  27. Change from 12 weeks to 16 weeks in kinematics during weight acceptance: hip range of motion

    Range of motion of the hip joint during walking on a treadmill

    Time frame: 16 weeks

  28. Change from 12 weeks to 16 weeks in kinematics during weight acceptance: knee range of motion

    Range of motion of the knee joint during walking on a treadmill

    Time frame: 16 weeks

  29. Change from 12 weeks to 16 weeks in kinematics during weight acceptance: ankle range of motion

    Range of motion of the ankle joint during walking on a treadmill

    Time frame: 16 weeks

  30. Change from 12 weeks to 16 weeks in kinematics during weight acceptance: hip acceleration

    Acceleration of the hip joint during walking on a treadmill

    Time frame: 16 weeks

  31. Change from 12 weeks to 16 weeks in kinematics during weight acceptance: knee acceleration

    Acceleration of the knee joint during walking on a treadmill

    Time frame: 16 weeks

  32. Change from 12 weeks to 16 weeks in kinematics during weight acceptance: ankle acceleration

    Acceleration of the ankle joint during walking on a treadmill

    Time frame: 16 weeks

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2022 (actual). Primary completion is estimated for Dec 2026, 55 months after the start.

Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's planned 55 months is above that.

Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 5, 2022
First posted
Apr 20, 2022
StartActual
May 17, 2022
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Dec 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05337982
Collaborators
University of Notre Dame, University of British Columbia, United States Department of Defense
Responsible party
Michele Basso (Professor, Ohio State University) — Principal investigator
First posted
Apr 20, 2022
Start date
May 17, 2022
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Dec 23, 2025

Study contacts

Michele Basso, EdD, PT
Contact
michele.basso@osumc.edu
614-814-1404
D. Michele Basso, EdD
principal investigator · Ohio State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion